Serial 99255257
Live / Allowed — Notice of allowance issued (as of 10 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99255257
- Mark type
- Design / logo
- Filed
- 26 Jun 2025
- Published for opposition
- 16 Dec 2025
- Attorney of record
- Jeffrey J. Scepanski
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of auditory and neurological diseases and disorders; Pharmaceutical preparations for gene therapy for the treatment of auditory and neurological diseases and disorders
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 10 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Dec 2025 — PUBLISHED FOR OPPOSITION
- 10 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Nov 2025 — ASSIGNED TO EXAMINER
- 05 Nov 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 05 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Jun 2025 — APPLICATION FILING RECEIPT MAILED